Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OZ Biosciences is a French biotechnology company specializing in the development of innovative molecular delivery systems for the worldwide life sciences research community and pharmaceutical industry. The company focuses on creating specialized transfection reagents and delivery technologies, such as its signature Magnetofection™ platform, which uses magnetic fields to concentrate vectors into target cells. Among its product portfolio is AlumVax Hydroxide, a high-quality aluminum hydroxide adjuvant used primarily in vaccine research to enhance immune responses. OZ Biosciences provides a wide range of tools for gene delivery, protein production, and vaccine development, supporting both basic research and preclinical drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NET (AlumVax Hydroxide).